Clinical Trial Update: A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain

View source ↗

Summary

A safety and effectiveness study evaluating immediate-release tapentadol hydrochloride for moderate to severe acute non-cancer pain in Filipino patients has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Acute Non-cancer Pain

Drugs mentioned

• Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Moderate to Severe Acute Non-Cancer Pain | Status: WITHDRAWN